The Efficacy and Safety of Total Glucosides of Peony in the Treatment of Primary Sjögren’s Syndrome: a Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

Xia Liu,Xiaomei Li,Xiangpei Li,Zhijun Li,Dongbao Zhao,Shengyun Liu,Miaojia Zhang,Fengxiao Zhang,Ping Zhu,Jinwei Chen,Wei,Bing Lin,Yingbo Zhou,Jing Chen,Yafei Pang,Lei Zhang,Xiaoxuan Sun,Zhibo Yu,Yun Jia,Jia Wang,Wenwen Sun,Frank Chiu,Liping Pang,Guochun Wang
DOI: https://doi.org/10.1007/s10067-018-4315-8
2018-01-01
Clinical Rheumatology
Abstract:The authors regret that the Fig. 1 in the original version of this article contained an error. In the left column, 211 cases in the TGP group should be followed up for 8 weeks before 12 weeks. The correct figure presented in this article.
What problem does this paper attempt to address?